Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis

CONCLUSION: ICS treatment in asthma and COPD patients is a risk factor for cataract development. Our results emphasize a previously underestimated potential long-term risk of treatment with ICS and underline the importance of targeting ICS treatment, and not least dosing, to improve the risk-benefit ratio of maintenance treatment in both asthma and COPD.PMID:37899845 | PMC:PMC10602708 | DOI:10.1155/2023/8209978
Source: Journal of Ophthalmology - Category: Opthalmology Authors: Source Type: research